Collectively, our study demonstrates that CPVL directly interacts with BTK to downregulate the STAT1 phosphorylation through promoting p300-mediated STAT1 acetylation, supporting the pursuit of CPVL as a potential target for glioma intervention. The gene discussed is EP300; the disease is glioma.